The ATUVIBI ConCiencia Grant 2026 offers a single €16,000 award to support basic, translational or clinical research on biliary tract cancers. Its first edition welcomes projects addressing intrahepatic, perihilar and distal extrahepatic cholangiocarcinoma, gallbladder carcinoma, and tumours of the ampulla of Vater.
The grant aims to improve diagnosis, treatment and other aspects of care that meaningfully benefit patients. Funded through community contributions and fundraising initiatives, the program gives priority to young or emerging research groups and requires mentorship to support project development.
Eligibility Criteria
- Applicants must be graduates affiliated with hospitals, universities or research centres in Spain.
- Applicants must have experience in biliary tract tumours.
- Priority is given to young or emerging research groups.
- Projects must address diagnosis, treatment or another relevant aspect of the specified tumour types.
- A mentor is required.
- Each principal investigator may submit one application.
- Each research group may submit a maximum of three projects.
Funding Details
- Award amount: €16,000.
- Number of awards: One.
- Project duration: Up to two years.
- Extensions may be approved for justified reasons by ATUVIBI’s Medical and Scientific Evaluation Committee.
- Eligible projects may involve basic, translational or clinical research.
Deadline
- Letter of intent: November 6, 2026.
- Invitations for full proposals: November 20, 2026.
- Full proposal submission: Before December 20, 2026.
- Decision announced: January 21, 2027.
- Grant presentation: February 18, 2027.
Further Information
Initial submissions require a letter of intent, project summary, bibliography, and applicant and mentor CVs. Selected applicants will be invited to submit a full proposal.